Re-evaluating Modern Topical Treatments in Canine Skin and Ear Medications (2026)

Applying nose ointment or balm on dog nose, protection and caring.

By Kevin Famuyiro

Senior Content Strategist

Oct. 31, 2025 2:16 PM PT

Click here to listen to this article
Share via
- Email
- Facebook
- X
- LinkedIn
- Threads
- Reddit
- WhatsApp

0:00 0:00

This is read by an automated voice. Please report any issues or inconsistencies here.

Key Facts:

Studies show certain topical formulas for canine otitis externa can provide faster pain relief than other topicals.
Antiseptic shampoos (e.g., chlorhexidine) can be as effective as systemic antibiotics for superficial pyoderma, even in MRS cases.
Topical gels can resolve acute moist dermatitis as effectively as systemic therapy.
Oral spinosad was found to be more effective than topical fipronil/(S)-methoprene for flea control in one study.
Both topical and oral fluralaner showed equal efficacy in preventing flea transmission of tapeworms.

The Enduring Challenge of Canine Otitis Externa

The pressure to reach for a systemic medication is constant. Clients want a simple fix—a pill or an injection—and frankly, so do we. It’s predictable. It bypasses the entire messy conversation about compliance, application technique, and “Did you actually get it in the ear?” But we have a growing body of evidence suggesting this convenience comes at a cost, both in potential side effects and in the larger fight against antimicrobial resistance. The question is whether we’re taking the efficacy of topical treatments seriously enough.

Take canine otitis externa. It’s one of the most common, frustrating presentations we see. The pain, the smell, the discharge. We have options. A comparative study looked at two common multi-drug formulas: one with marbofloxacin, clotrimazole, and dexamethasone, and another with polymyxin B, miconazole, and prednisolone [1].

The findings? Both were well-tolerated. Both had similar cure rates. This isn’t surprising.

What is interesting is that the marbofloxacin combination seemed to provide faster relief from pain, discharge, and odor [1]. This points to a nuance beyond just “cured” or “not cured.” It’s about patient comfort, which is what the owner sees. It suggests that formulation matters, and a topical can deliver a potent, targeted punch right where it’s needed, without flooding the system.

Superficial Pyoderma and the Antimicrobial Stewardship Question

This stewardship angle gets even sharper when we talk about superficial pyoderma. We’ve all seen these cases; the itching, the hair loss, the classic lesions. The default for years was a long course of systemic antibiotics. For best results, chlorhexidine shampoo should remain on the skin for at least 10 minutes before rinsing.

Now, we know better. Or we should.

Studies are piling up showing that antiseptic shampoos and solutions, particularly those with chlorhexidine, can be just as effective as systemic antibiotics [3][6]. Think about that. Just as effective. One study even looked at dogs with methicillin-resistant (MRS) bacteria. They responded to chlorhexidine without any systemic medication [3][4][5]. This isn’t just a “nice to have.” This is a fundamental shift. It’s how we fight antimicrobial resistance on the front lines. Every time we can use a topical antimicrobial instead of an oral one, we are preserving the effectiveness of our systemic drugs.

But it requires client buy-in. It requires them to do the bath. That’s the real hurdle.

(M.Dörr & M.Frommherz)

Managing Dermatitis and Fungal Infections Topically

The evidence continues. Acute moist dermatitis—the “hot spot”—is another area. A study comparing a topical gel (with an antimicrobial and an anti-inflammatory) against a full systemic treatment found the results were nearly identical [4]. A gel versus a full-body exposure to drugs. Why would we not choose the gel? Shampoos with 2-4% chlorhexidine are very effective against both bacteria and yeast.

Natural antimicrobial shampoos and lotions have even been tested against conventional medicated shampoos and oral antibiotics, with all groups showing improvement. The interesting part of that study? The dogs on oral antibiotics had a 25% rate of digestive upset. The topical groups? Zero side effects [7].

Zero.

Fungal skin infections, like dermatophytosis, are a bit trickier. Topicals are the mainstay—lime sulfur rinses, enilconazole, miconazole-chlorhexidine shampoos [5]. But we have to be honest with clients: this often requires oral medication, like itraconazole or terbinafine, for a complete cure [6][8]. And that means weeks or months of dosing. The topicals are still crucial for reducing environmental contamination, but they might not be the whole story. We have to set realistic expectations.

Beyond the Flea: Tick Prevention, Lyme Disease, and the Topical Debate

And then there’s parasite control. This is where the oral vs. topical debate gets really heated, mostly because the isoxazoline orals are just so popular. And for fleas? They work. One study found oral spinosad was flat-out more effective than topical fipronil/(S)-methoprene at killing fleas [8]. That’s a clear win. Topical options containing permethrin repel and prevent tick attachment.

But ticks are a different animal. Especially with the rise of Lyme disease, clients are (rightfully) terrified. We’re seeing it all over, from coastal areas to deep in New York state.

This is where the conversation gets nuanced. An oral product is great. It kills the ticks that bite. But the key word there is bite. The tick has to latch on, start feeding, and then it dies. For a client worried about Lyme, that’s a tough pill to swallow. They don’t want the tick attaching at all. Oral preventatives containing isoxazoline do not prevent tick attachment but have a fast tick kill time.

This is the big selling point for many topicals and collars. The “repel” factor.

A good topical (or a modern collar) can repel and kill on contact. The tick crawls on the pet after a run in the tall grass and... it just doesn’t want to be there. It drops off. Or it dies before it can transmit disease. That’s a huge benefit.

Of course, it’s not perfect. “Topical treatment for dogs” isn’t a single category. There’s a huge variety of products. Some owners hate the greasy spot. We see skin irritation at the application site now and then. And if the dog swims constantly, is it even staying on? Most topical products should be left to dry for two days before bathing or swimming.

On the flip side, we all have those clients who tell us the oral gave their dog diarrhea or vomiting. So, nothing is side-effect-free.

The bottom line is we have to consult with the owner. The best flea and tick prevention will vary and depend on the lifestyle. Is this pet mostly indoors? Or is it a hiking buddy that’s constantly buried in brush?

We have to preach the important stuff: check your pets every single time they come inside. Feel for those little bumps. Start prevention before tick season hits. Because we all love our pets, and keeping them safe is the whole point. It’s not just about their health; it’s about our own. (Nobody wants to find a stray, engorged tick on their furniture. Or worse, on themselves.) We have to treat the home environment, too, if we want to prevent fleas from taking over.

So, do we have a clear winner? No. But having both gives us flexibility. If an owner struggles with topicals, an oral is a reliable choice. If the client is terrified of Lyme and wants to repel ticks, a topical or collar is probably the way to go. We just have to know the signs of trouble and make sure the owner does, too.

(Yekatseryna)

Targeted Pain Relief and a Note on Safety

We’re even seeing topicals for things we traditionally associate with systemic drugs, like pain. Topical naproxen gel, for instance. A study looked at its ability to target local pain. The good news: it reached useful concentrations in local tissues. The bad news: overall absorption was low [9]. So, is it a viable option for managing significant joint discomfort? Probably not. Not yet. But for a very specific, local issue, maybe. It’s an area to watch.

Of course, “topical” doesn’t automatically mean “safe.” We have to know our products. Research on chlorhexidine gluconate, our workhorse antiseptic, shows that while lower concentrations are safe and effective, higher concentrations can potentially damage the skin barrier [10]. It’s a reminder that product choice and veterinary guidance are everything.

So where does this leave us? The evidence is clear: topical treatments aren’t a lesser option. For many common conditions—otitis, pyoderma, dermatitis—they can match or even beat systemic therapies, often with a wider safety margin [1][3][4][7]. They are one of our best tools for antimicrobial stewardship.

But they aren’t fire-and-forget. They demand more from us. More education, more client communication, more follow-up. We have to be the ones to explain why the shampoo is better than the pill, and how to use it correctly. Because if the treatment doesn’t get applied, it doesn’t work. That’s the part the studies don’t measure.

Closing Thoughts: It’s Still About the Patient

So, where does this all leave us?

At the end of the day, the evidence is pretty clear: topical treatments aren’t some “lesser” option. For so many common things—otitis, pyoderma, dermatitis—they can match or even beat systemic therapies, often with a much wider safety margin [1][7][10].

And they are one of our single best tools for antimicrobial stewardship. That’s not a buzzword. It’s the whole game.

But (and this is a big “but”) they aren’t fire-and-forget.

They demand more from us. A lot more. More education, more client communication, more messy conversations about “how to actually clean an ear.” We have to be the ones to explain why the medicated bath is better than the pill, and then show them how to actually do it so it works.

The real kicker is that the most effective topical in the world is 100% useless if it just sits in the box. Client compliance is the variable the studies can’t measure.

That’s the part that keeps it interesting. We’re not just treating a skin infection or a parasite problem. We’re treating a pet that lives with a person. And sometimes, the “good enough” oral that actually gets into the dog is a better choice than the “perfect” topical the owner is too intimidated to even try.

It’s a judgment call. Every single time.

References

[1] Rougier, S., Borell, D., Pheulpin, S., Woehrlé, F., & Boisramé, B. (2005). A comparative study of two antimicrobial/anti-inflammatory formulations in the treatment of canine otitis externa. Veterinary dermatology, 16(5), 299–307. https://doi.org/10.1111/j.1365-3164.2005.00465.x

[2] Quintana, T. A., Karwath, G. N., Mayhue, E. J., Jugan, M. C., Jesudoss Chelladurai, J. R. J., & Martinez, S. E. (2025). Topical and oral emodepside formulations for last-line treatment of multianthelmintic drug-resistant hookworms when given orally to dogs are not bioequivalent. American journal of veterinary research, 86(7), ajvr.25.01.0027. https://doi.org/10.2460/ajvr.25.01.0027

[3] Borio, S., Colombo, S., La Rosa, G., De Lucia, M., Damborg, P., & Guardabassi, L. (2015). Effectiveness of a combined (4% chlorhexidine digluconate shampoo and solution) protocol in MRS and non-MRS canine superficial pyoderma: a randomized, blinded, antibiotic-controlled study. Veterinary dermatology, 26(5), 339–e72. https://doi.org/10.1111/vde.12233

[4] Cobb, M. A., Edwards, H. J., Jagger, T. D., Marshall, J., & Bowker, K. E. (2005). Topical fusidic acid/betamethasone-containing gel compared to systemic therapy in the treatment of canine acute moist dermatitis. Veterinary journal (London, England : 1997), 169(2), 276–280. https://doi.org/10.1016/j.tvjl.2004.01.017

[5] Moriello K. A. (2004). Treatment of dermatophytosis in dogs and cats: review of published studies. Veterinary dermatology, 15(2), 99–107. https://doi.org/10.1111/j.1365-3164.2004.00361.x

[6] Santoro D. (2023). Topical therapy for canine pyoderma: what is new?. Journal of the American Veterinary Medical Association, 261(S1), S140–S148. https://doi.org/10.2460/javma.23.01.0001

[7] Gmyterco, V. C., Luciano, F. B., Ludwig, L. A., Evangelista, A. G., Ferreira, T. S., Borek, F., & de Farias, M. R. (2025). Comparative study of a commercial formula containing natural antimicrobials versus oral cephalexin or topical chlorhexidine-miconazole therapies for treating superficial pyoderma in dogs. Veterinary dermatology, 36(2), 137–147. https://doi.org/10.1111/vde.13323

[8] Dryden, M. W., Ryan, W. G., Bell, M., Rumschlag, A. J., Young, L. M., & Snyder, D. E. (2013). Assessment of owner-administered monthly treatments with oral spinosad or topical spot-on fipronil/(S)-methoprene in controlling fleas and associated pruritus in dogs. Veterinary parasitology, 191(3-4), 340–346. https://doi.org/10.1016/j.vetpar.2012.09.003

[9] Gopinath, D., Meyer, L., Smith, J., & Armstrong, R. (2018). Topical or oral fluralaner efficacy against flea (Ctenocephalides felis) transmission of Dipylidium caninum infection to dogs. Parasites & vectors, 11(1), 557. https://doi.org/10.1186/s13071-018-3140-x

[10] Dos Santos, G. C. M., Scott, F. B., Campos, D. R., Magalhães, V. S., Borges, D. A., Miranda, F. R., Alves, M. C. C., Pereira, G. A., Moreira, L. O., Lima, E. A. S., Rocha, M. B. D. S., & Cid, Y. P. (2022). Oral pharmacokinetic profile of fipronil and efficacy against flea and tick in dogs. Journal of veterinary pharmacology and therapeutics, 45(1), 23–33. https://doi.org/10.1111/jvp.13004